Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Atomo Diagnostics Ltd. ( (AU:AT1) ) has issued an announcement.
Atomo Diagnostics Limited announced the resignation of Paul Kasian from its board of directors, effective May 2, 2025. This change in leadership may influence the company’s strategic direction and stakeholder relations, as Kasian held significant shares through Yongala Investments Pty Ltd, indicating his substantial involvement in the company’s operations.
More about Atomo Diagnostics Ltd.
Atomo Diagnostics Limited operates in the medical diagnostics industry, focusing on the development and commercialization of rapid diagnostic test devices. The company’s primary products include innovative testing solutions that aim to deliver accurate and timely health information, catering to both healthcare professionals and consumers.
Average Trading Volume: 458,408
Technical Sentiment Signal: Buy
Current Market Cap: A$12.14M
Learn more about AT1 stock on TipRanks’ Stock Analysis page.